Skip to content
Home/Companies/Biotech/Action Pharma

Action Pharma

Biotech·Denmark·Exited 2012·Held 10yr
Entry
2002
Hold
10yr
Exit
2012

Who owns Action Pharma?

Action Pharma was owned by Capnova through CAPNOVA (1998 vintage) from 2002 to 2012, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-19

Capnova
Investor
Capnova
CAPNOVA · 1998 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2012

More from CAPNOVA

Other portfolio companies in the same fund.

Triband
Exited 2020
GamingDenmark· 2016
to
SynAct Pharma
Exited 2016
BiotechDenmark· 2012
SYBO Games
Exited 2012
GamingDenmark· 2011
MediConnect
Exited 2005
HealthTechDenmark· 2001
to
Aros Applied Biotechnology
Exited 2013
BiotechDenmark· 2000
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Action Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Action Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Action Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue